Effect of cabergoline on vascular permeability markers with the risk of ovarian hyperstimulation syndrome
- Authors: Fetisova S.V1, Korneeva I.E1, Saroyan T.T1, Krechetova L.V1, Podrez L.A1
-
Affiliations:
- Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
- Issue: No 5 (2014)
- Pages: 57-61
- Section: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/247183
- ID: 247183
Cite item
Abstract
Full Text
About the authors
S. V Fetisova
Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: svfetisova@mail.ru
postgraduate student at the 1st gynecological department
I. E Korneeva
Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: irina.korneeva@inbox.ru
MD, leading researcher, doctor of the highest category, 1st gynecological department
T. T Saroyan
Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: tata-l976@mail.ru
PhD, researcher at the 1st gynecological department
L. V Krechetova
Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: k_l_v_@mail.ru
PhD, head of the Laboratory of Clinical Immunology
L. A Podrez
Academician V.I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia
Email: mylude@rambler.ru
doctor, laboratory of clinical immunology
References
- Delvigne A., Rozenberg S. Epidemiology and prevention of ovarian hyperstimulation syndrome (ohss): a review. Hum. Reprod. Update. 2002; 8: 559-77.
- Soares S.R. Etiology of OHSS and use of dopamine agonists. Fertil. Steril. 2012; 97(3): 517-22.
- Gomez R., Simon C., Remohi J., Pellicer A. Administration of moderate and high doses of gonadotrophins to female rats increases ovarian vascular endothelial growth factor (VEGF) and VEGF receptor-2 expression that is associated to vascular hyperpermeability. Biol. Reprod. 2003; 68: 2164-71.
- Ferrara N., Kerbel R.S. Angiogenesis as a therapeutic target. Nature. 2005; 438: 967-74.
- Gille H., Kowalski J., Li B., Le Couter J., Moffat B., Zioncheck T.F. et al. Analysis of biological effects and signaling properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2). A reassessment using novel receptor-specific vascular endothelial growth factor mutants. J. Biol. Chem. 2001; 276(5): 3222-30.
- Soares S.R., Gomez R., Simon С. Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome. Hum. Reprod. Update. 2008; 14(4): 321-33.
- Papaleo E., Doldi N., De Santis L., Marelli G., Marsiglio E., Rofena S., Ferrari A. Cabergoline influences ovarian stimulation in hyperprolactinaemic patients with polycystic ovary syndrome. Hum. Reprod. 2001; 16(11): 2263-6.
- Pau E. Plasma levels of soluble vascular endothelial growth factor receptor-1 may determine the onset of early and late ovarian hyperstimulation syndrome. Hum. Reprod. 2006; 21(6): 1453-60.
- Pietrowski D. Ovarian hyperstimulation syndrome is correlated with a reduction of soluble VEGF receptor protein level and a higher amount of VEGF-A. Hum. Reprod. 2012; 27(1): 196-9.